Home
Advanced Search
Help
Update History
Statistics
Downloads
The Barton Group

Predicted interactions involving protein CSK: Tyrosine-protein kinase CSK (IPI00013212) that score above 2.5

Click on the protein name for more information about the protein.

The Score column is the predicted score of interaction between the two proteins

Click on the Evidence link to view a breakdown of the information about the predicted interaction.

Key
Module ScoreDatabases
Where interaction is observed in another database a link is provided:

Protein 1 (?)Protein 2 (?) Name of Protein 2 Module Scores (?) Scores (?) Evidence (?) Database (?)
CSK STAT6 STAT6: Signal transducer and activator of transcription 6 1.53E3 Evidence
CSK TYK2 TYK2: Non-receptor tyrosine-protein kinase TYK2 1.17E3 Evidence
CSK VAV1 VAV1, VAV: Proto-oncogene vav 1.17E3 Evidence
CSK SYK SYK: Tyrosine-protein kinase SYK 720.0 Evidence
CSK JAK2 JAK2: Tyrosine-protein kinase JAK2 674.0 Evidence
CSK BTK BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK 549.0 Evidence
CSK NCK1 NCK1, NCK: Cytoplasmic protein NCK1 549.0 Evidence
CSK ZAP70 ZAP70: Uncharacterized protein ZAP70 497.0 Evidence
CSK CRKL CRKL: Crk-like protein 408.0 Evidence
CSK NCK2 NCK2: Cytoplasmic protein NCK2 408.0 Evidence
CSK SH3BP2 SH3BP2: Uncharacterized protein SH3BP2 370.0 Evidence
CSK LCP2 LCP2: Lymphocyte cytosolic protein 2 364.0 Evidence
CSK STAT5B STAT5B: Signal transducer and activator of transcription 5B 306.0 Evidence
CSK CSF1R CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor 305.0 Evidence
CSK STAT5A STAT5A, STAT5: Signal transducer and activator of transcription 5A 301.0 Evidence
CSK APS SH2B2, APS: SH2B adapter protein 2 268.0 Evidence
CSK WAS WAS, IMD2: Wiskott-Aldrich syndrome protein 226.0 Evidence
CSK HCLS1 HCLS1, HS1: Hematopoietic lineage cell-specific protein 226.0 Evidence
CSK WASPIP N/A 194.0 Evidence
CSK SH2D2A SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A 181.0 Evidence
CSK SRC SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src 181.0 Evidence
CSK MAP4K1 MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 165.0 Evidence
CSK TXK TXK, PTK4: Tyrosine-protein kinase TXK 162.0 Evidence
CSK KIT KIT: Mast/stem cell growth factor receptor precursor 149.0 Evidence
CSK PDGFRB PDGFRB: Beta-type platelet-derived growth factor receptor precursor 134.0 Evidence
CSK FLT1 FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor 134.0 Evidence
CSK PTPN6 PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 119.0 Evidence
CSK LNK SH2B3, LNK: SH2B adapter protein 3 119.0 Evidence
CSK ABL1 ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 109.0 Evidence
CSK STAT3 106.0 Evidence
CSK ITK ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK 106.0 Evidence
CSK RASA1 RASA1, RASA: Ras GTPase-activating protein 1 106.0 Evidence
CSK PTK2B PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta 106.0 Evidence
CSK STAT1 STAT1: Signal transducer and activator of transcription 1-alpha/beta 104.0 Evidence
CSK TEC TEC, PSCTK4: Tyrosine-protein kinase Tec 98.20 Evidence
CSK AXL AXL, UFO: Tyrosine-protein kinase receptor UFO precursor 89.20 Evidence
CSK KHDRBS1 KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate 87.80 Evidence
CSK RET RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor 79.90 Evidence
CSK CBL CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL 78.20 Evidence O
CSK PIK3R2 PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta 71.10 Evidence
CSK RAF1 RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase 64.00 Evidence
CSK GRAP GRAP: GRB2-related adapter protein 61.00 Evidence
CSK CBLC CBLC, CBL3, RNF57: Signal transduction protein CBL-C 58.60 Evidence
CSK GRB10 N/A 56.20 Evidence
CSK PCBP1 PCBP1: Poly(rC)-binding protein 1 53.40 Evidence
CSK IGF1R IGF1R: Insulin-like growth factor 1 receptor precursor 52.50 Evidence O
CSK KDR KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor 52.50 Evidence
CSK INSR INSR: Insulin receptor precursor 47.30 Evidence
CSK EPHB2 EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor 47.30 Evidence
CSK TEK TEK, TIE2: Angiopoietin-1 receptor precursor 47.20 Evidence
CSK PCBP2 PCBP2: Poly(rC)-binding protein 2 45.90 Evidence
CSK SH2D1A SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A 44.70 Evidence
CSK DOK1 DOK1: Docking protein 1 44.40 Evidence
CSK CD2AP CD2AP: CD2-associated protein 42.00 Evidence
CSK PIK3CG PIK3CG: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma i 42.00 Evidence
CSK NMT1 NMT1, NMT: Glycylpeptide N-tetradecanoyltransferase 1 35.00 Evidence
CSK NRBP1 NRBP1, BCON3, NRBP: Nuclear receptor-binding protein 33.90 Evidence
CSK CD22 CD22, SIGLEC2: B-cell receptor CD22 precursor 30.90 Evidence
CSK CD79A CD79A, IGA, MB1: B-cell antigen receptor complex-associated protein alpha-chain 30.90 Evidence
CSK ACP1 ACP1: Low molecular weight phosphotyrosine protein phosphatase 25.00 Evidence
CSK SLAMF1 SLAMF1, SLAM: Signaling lymphocytic activation molecule precursor 24.90 Evidence
CSK SRMS SRMS, C20orf148: Tyrosine-protein kinase Srms 24.10 Evidence
CSK BRDG1 STAP1, BRDG1: Signal-transducing adaptor protein 1 24.10 Evidence
CSK HD HD, IT15: Huntingtin 23.60 Evidence
CSK PASK PASK, KIAA0135: PAS domain-containing serine/threonine-protein kinase 22.80 Evidence
CSK HLA-F HLA-F, HLA-5.4, HLAF: HLA class I histocompatibility antigen, alpha chain F prec 21.00 Evidence
CSK IL2RB IL2RB: Interleukin-2 receptor subunit beta precursor 18.40 Evidence
CSK CSF2RB CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor 18.40 Evidence
CSK CDC25A CDC25A: M-phase inducer phosphatase 1 17.60 Evidence
CSK PRKAA1 N/A 17.30 Evidence
CSK EIF4G2 EIF4G2, DAP5, OK/SW-cl.75: Eukaryotic translation initiation factor 4 gamma 2 16.30 Evidence
CSK SNCA SNCA, NACP, PARK1: Alpha-synuclein 15.00 Evidence
CSK ELMO1 N/A 13.40 Evidence
CSK NEDD9 NEDD9, CASL: Enhancer of filamentation 1 13.40 Evidence
CSK PDPK1 PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 13.40 Evidence
CSK PRKCQ PRKCQ, PRKCT: Protein kinase C theta type 12.40 Evidence
CSK PRKCE PRKCE, PKCE: Protein kinase C epsilon type 11.80 Evidence
CSK HNRPK N/A 11.70 Evidence
CSK STAG2 STAG2, SA2: Cohesin subunit SA-2 11.70 Evidence
CSK PTPN2 PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 11.60 Evidence
CSK PRKCG PRKCG, PKCG: Protein kinase C gamma type 11.60 Evidence
CSK PECAM1 PECAM1: Platelet endothelial cell adhesion molecule precursor 11.40 Evidence
CSK ACTG1 ACTB: Actin, cytoplasmic 1 10.80 Evidence
CSK TGFBR1 TGFBR1: TGF-beta receptor type-1 precursor 10.70 Evidence
CSK TYRO3 TYRO3, BYK, DTK, RSE, SKY: Tyrosine-protein kinase receptor TYRO3 precursor 10.40 Evidence
CSK HSP90AA1 Hsp89-alpha-delta-N 10.30 Evidence
CSK PLD2 PLD2: Phospholipase D2 10.00 Evidence
CSK MAPK3 MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 10.00 Evidence
CSK ADAM15 ADAM15, MDC15: ADAM 15 precursor 9.92 Evidence
CSK TRPV4 TRPV4, VRL2, VROAC: Transient receptor potential cation channel subfamily V memb 9.92 Evidence
CSK CD79B CD79B, B29, IGB: B-cell antigen receptor complex-associated protein beta-chain p 9.92 Evidence
CSK FCGR2B FCGR2B, CD32, FCG2, IGFR2: Low affinity immunoglobulin gamma Fc region receptor 9.92 Evidence
CSK PTPRC PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ 9.92 Evidence
CSK SMAD2 SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 9.17 Evidence
CSK PRKCA PRKCA, PKCA, PRKACA: Protein kinase C alpha type 8.86 Evidence
CSK DAB2 DAB2, DOC2: Disabled homolog 2 8.86 Evidence
CSK TNKS2 TNKS2, PARP5B, TANK2, TNKL: Tankyrase-2 8.81 Evidence
CSK EIF4G3 EIF4G3: Eukaryotic translation initiation factor 4 gamma 3 8.00 Evidence
CSK UBAP2L UBAP2L, KIAA0144, NICE4: Ubiquitin-associated protein 2-like 7.93 Evidence
CSK DAPP1 N/A 7.93 Evidence
CSK AKAP12 AKAP12, AKAP250: A-kinase anchor protein 12 7.59 Evidence
CSK HNRPK HNRPK, HNRNPK: Heterogeneous nuclear ribonucleoprotein K 7.59 Evidence
CSK SCAP2 SKAP2, PRAP, RA70, SAPS, SCAP2, SKAP55R: Src kinase-associated phosphoprotein 2 7.57 Evidence
CSK FASLG FASLG, APT1LG1, FASL, TNFSF6: Tumor necrosis factor ligand superfamily member 6 7.40 Evidence
CSK CD5 CD5, LEU1: T-cell surface glycoprotein CD5 precursor 7.40 Evidence
CSK YWHAB YWHAB: 14-3-3 protein beta/alpha 7.10 Evidence
CSK PPP1R12A PPP1R12A, MBS, MYPT1: Protein phosphatase 1 regulatory subunit 12A 7.10 Evidence
CSK MTMR1 MTMR1: Myotubularin-related protein 1 6.78 Evidence
CSK PRKX PRKX, PKX1: Serine/threonine-protein kinase PRKX 6.78 Evidence
CSK IKBKG IKBKG, FIP3, NEMO: NF-kappa-B essential modulator 6.71 Evidence
CSK EPOR EPOR: Erythropoietin receptor precursor 6.52 Evidence
CSK SH3BP1 SH3BP1: SH3 domain-binding protein 1 6.11 Evidence
CSK PPP1R8 N/A 6.01 Evidence
CSK ITGB4 N/A 5.88 Evidence
CSK BCAR1 BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 5.50 Evidence
CSK DUSP2 DUSP2, PAC1: Dual specificity protein phosphatase 2 5.33 Evidence
CSK LYN LYN: Tyrosine-protein kinase Lyn 5.22 Evidence
CSK BFAR BFAR, BAR, RNF47: Bifunctional apoptosis regulator 4.80 Evidence
CSK FCER1G FCER1G: High affinity immunoglobulin epsilon receptor subunit gamma precursor 4.80 Evidence
CSK TCF3 TCF3, E2A, ITF1: Transcription factor E2-alpha 4.77 Evidence
CSK SYNCRIP SYNCRIP, HNRPQ, NSAP1: Heterogeneous nuclear ribonucleoprotein Q 4.77 Evidence
CSK DNM1 DNM1, DNM: Dynamin-1 4.68 Evidence
CSK NULL Ig lambda chain V-I region EPS 4.68 Evidence
CSK IGHE IGHE: Ig epsilon chain C region 4.68 Evidence
CSK PPP3R1 PPP3R1, CNA2, CNB: Calcineurin subunit B isoform 1 4.51 Evidence
CSK S100A4 S100A4, CAPL, MTS1: Protein S100-A4 4.51 Evidence
CSK PLAUR PLAUR, MO3, UPAR: Urokinase plasminogen activator surface receptor precursor 4.48 Evidence
CSK EVL N/A 4.23 Evidence
CSK HSPD1 4.23 Evidence
CSK PTPN11 N/A 4.23 Evidence
CSK CASP3 CASP3, CPP32: Caspase-3 precursor 4.23 Evidence
CSK CD19 N/A 4.06 Evidence
CSK GRIA3 GRIA3, GLUR3, GLURC: Glutamate receptor 3 precursor 4.01 Evidence
CSK CREBBP CREBBP, CBP: CREB-binding protein 3.85 Evidence O
CSK SMAD3 SMAD3, MADH3: Mothers against decapentaplegic homolog 3 3.85 Evidence
CSK CD36 CD36, GP3B, GP4: Platelet glycoprotein 4 3.69 Evidence
CSK GTF2B GTF2B, TF2B, TFIIB: Transcription initiation factor IIB 3.64 Evidence
CSK ZNF217 ZNF217, ZABC1: Zinc finger protein 217 3.64 Evidence
CSK DHX16 DHX16, DBP2, DDX16, KIAA0577: Putative pre-mRNA-splicing factor ATP-dependent RN 3.64 Evidence
CSK BLNK BLNK, BASH, SLP65: B-cell linker protein 3.52 Evidence
CSK KPNA2 KPNA2, RCH1, SRP1: Importin subunit alpha-2 3.47 Evidence
CSK AQP2 AQP2: Aquaporin-2 3.18 Evidence
CSK JAK1 3.15 Evidence
CSK FGR FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR 3.15 Evidence
CSK GJB1 GJB1, CX32: Gap junction beta-1 protein 3.08 Evidence
CSK CD48 CD48, BCM1, BLAST1: CD48 antigen precursor 3.01 Evidence
CSK ZYX ZYX: Zyxin 2.94 Evidence
CSK SLA SLA, SLAP, SLAP1: SRC-like-adapter 2.84 Evidence
CSK CTLA4 CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor 2.77 Evidence
CSK AGTR1 AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor 2.65 Evidence
CSK TXN TXN, TRDX, TRX, TRX1: Thioredoxin 2.63 Evidence
CSK MATK 2.54 Evidence
CSK CASP9 CASP9, MCH6: Caspase-9 precursor 2.54 Evidence